For example, treatment of metastatic colorectal cancer patients with cetuximab drives CD8+ T cell infiltration as well as upregulation of PD-L1, the latter of which can be blocked by avelumab (59). The gene discussed is CD8A; the disease is metastatic colorectal cancer.